Table 1.
Detrimental effects of ROS in skeletal muscle.
Process | Mechanism | Effect | References |
---|---|---|---|
Aging myocytes | Oxidation of mtDNA |
|
Picard et al., 2014 |
mPTP opening |
|
Lemasters et al., 2009; Barbieri and Sestili, 2012 | |
AIF and Endo G release |
|
Barbieri and Sestili, 2012 | |
Induced activity of proteases and nucleases |
|
Cadenas and Davies, 2000 | |
Skeletal muscle contraction | Activation of calpains and caspases |
|
Ochala et al., 2011 |
Nitrosylation of RyR1 receptor |
|
Bellinger et al., 2009; Westerblad and Allen, 2011 | |
Oxidation of sarcolemmal lipids or contractile proteins |
|
Goldstein and Mcnally, 2010 | |
Neuromuscular function | SOD1 deficiency |
|
Fischer et al., 2011, 2012 |
Chronic muscle disuse | Decreased mitochondrial content; increased ROS production and apoptosis signaling |
|
Adhihetty et al., 2007 |
AIF, apoptosis inducing factor; Endo G, mitochondrial endonuclease G; mPTP, mitochondrial permeability transition pore; mtDNA, mitochondrial DNA; SOD1, Cu, Zn-superoxide dismutase.